文献速递糖尿病

TLR9负向调控1型糖尿病小鼠胰岛β细胞生长与功能

Toll-like receptor 9 negatively regulates pancreatic islet beta cell growth and function in a mouse model of type 1 diabetes.
PubMed 文献 · Diabetologia · 2018-08-09

该研究在NOD小鼠中构建Tlr9-/-模型,发现TLR9缺失促进胰岛发育和β细胞分化,改善糖耐量、胰岛素敏感性和第一时相胰岛素分泌,部分由CD140a上调介导;遗传靶向或TLR9拮抗剂处理均使NOD小鼠免于糖尿病。

要点

  • TLR9缺失促进NOD小鼠胰岛发育和β细胞分化。
  • TLR9缺失改善糖耐量、胰岛素敏感性和第一时相胰岛素分泌。
  • TLR9拮抗剂处理野生型NOD小鼠可模拟TLR9缺失的保护效应。

核心结论

  • TLR9与CD140a通路共同调控胰岛β细胞发育和功能,提示其可能成为糖尿病预防和/或治疗靶点。

研究设计与样本

  • 研究使用NOD小鼠构建Tlr9-/-模型,检测1型糖尿病发生及β细胞功能(胰岛素分泌和糖耐量),并用流式细胞术评估胰岛和β细胞数量及CD140a表达。
  • 研究还在Tlr9-/- C57BL/6小鼠中检测β细胞功能,并用TLR9拮抗剂阻断野生型NOD小鼠TLR9信号以验证其作用。

主要发现

  • TLR9缺失促进胰岛发育和β细胞分化,导致糖耐量增强、胰岛素敏感性改善和第一时相胰岛素分泌反应增强。
  • 该效应部分由CD140a(PDGFRα)上调介导。
  • 遗传靶向或TLR9拮抗剂处理对β细胞个体发生和功能有相似效应,均使NOD小鼠免于糖尿病。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Innate immune effectors interact with the environment to contribute to the pathogenesis of the autoimmune disease, type 1 diabetes. Although recent studies have suggested that innate immune Toll-like receptors (TLRs) are involved in tissue development, little is known about the role of TLRs in tissue development, compared with autoimmunity. We aimed to fill the knowledge gap by investigating the role of TLR9 in the development and function of islet beta cells in type 1 diabetes, using NOD mice. METHODS: We generated Tlr9-/- NOD mice and examined them for type 1 diabetes development and beta cell function, including insulin secretion and glucose tolerance. We assessed islet and beta cell number and characterised CD140a expression on beta cells by flow cytometry. We also tested beta cell function in Tlr9-/- C57BL/6 mice. Finally, we used TLR9 antagonists to block TLR9 signalling in wild-type NOD mice to verify the role of TLR9 in beta cell development and function. RESULTS: TLR9 deficiency promoted pancreatic islet development and beta cell differentiation, leading to enhanced glucose tolerance, improved insulin sensitivity and enhanced first-phase insulin secretory response. This was, in part, mediated by upregulation of CD140a (also known as platelet-derived growth factor receptor-α [PDGFRα]). In the absence of TLR9, induced by either genetic targeting or treatment with TLR9 antagonists, which had similar effects on ontogenesis and function of beta cells, NOD mice were protected from diabetes. CONCLUSIONS/INTERPRETATION: Our study links TLR9 and the CD140a pathway in regulating islet beta cell development and function and indicates a potential therapeutic target for diabetes prevention and/or treatment.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Liu M, Peng J, Tai N, et al. Toll-like receptor 9 negatively regulates pancreatic islet beta cell growth and function in a mouse model of type 1 diabetes. Diabetologia. 2018. PMID: 30094467. doi:10.1007/s00125-018-4705-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。